+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Microfluidics Market by Material (Glass-based, Polymer-based, Silicon-based), Component (Micro Needle, Micro Pump, Microfluidic Chip), Application, End User - Forecast 2023-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968817
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Microfluidics Market size was estimated at USD 20.50 billion in 2022, USD 25.53 billion in 2023, and is expected to grow at a CAGR of 25.26% to reach USD 124.31 billion by 2030.

Microfluidics is a multidisciplinary scientific field that deals with the precise control, manipulation, and analysis of fluids at a microscale level, typically in microliters to picoliters. Microfluidics integrates principles from diverse disciplines such as physics, engineering, chemistry, and biology to facilitate operations on small volumes of fluids using microfabricated devices featuring channels with dimensions ranging from tens to hundreds of micrometers. Increasing global investments in life sciences research have accelerated the demand for innovative tools and technologies. Microfluidic devices offer advantages such as high throughput screening capabilities and precise control over fluid handling at low volumes, making them attractive tools for researchers. Advances in healthcare infrastructure focusing on precision medicine have also contributed to an increased adoption of microfluidic technologies for diagnostic purposes. However, the complexity associated with designing, fabricating, and integrating microfluidic devices into current laboratory workflows and standardization issues arising due to different fabrication methods significantly impedes the usage of microfluidics. In addition, manufacturers focus on developing wearable diagnostic devices that employ microfluidic technologies to monitor patients' health in real-time.

Regional Insights

In the Americas, the United States and Canada emerged as key players in the microfluidics market due to their robust healthcare infrastructure and strong focus on research, which has led to increased investment from the public and private sectors. The National Institutes of Health (NIH) invests heavily in microfluidics research to advance personalized medicine and develop innovative diagnostic solutions. Countries such as China, Japan, and India showcase immense growth potential in microfluidics in the Asia-Pacific region. In China, numerous research institutions backed by government initiatives focus on developing novel microfluidic platforms for applications such as clinical diagnostics and environmental monitoring. European Union (EU) countries contribute significantly to developing microfluidics technologies, with numerous academic institutions working closely with industries for commercialization. The MEA region is developing interest in adopting cutting-edge medical technologies, including microfluidics, for diagnostic purposes. Countries, including Saudi Arabia and the UAE, have invested in state-of-the-art healthcare facilities that utilize advanced tools such as lab-on-a-chip systems for rapid disease detection.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Microfluidics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Microfluidics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Microfluidics Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc., Abbott Laboratories, AbCellera Biologics Inc., Achira Labs Pvt. Ltd., Agilent Technologies, Inc., Ascent Bio-Nano Technologies, Inc., Bio-Rad Laboratories, Inc., BioFluidica, Biosurfit SA, Camozzi Automation S.p.A., Cellix Limited, Danaher Corporation, Dolomite Microfluidics, Elvesys Group, Fluidigm Corporation by Standard BioTools Inc., Fluigent S.A., Idex Corporation, Illumina, Inc., IMT Masks and Divisions AG, Koninklijke Philips N.V., Micropoint Bioscience, Inc., Mission Bio, Inc., NanoCellect Biomedical., OPKO Health, Inc., Parker-Hannifin Corporation, PerkinElmer Inc., Quidel Corporation, SMC Corporation, Sphere Fluidics Limited, and Thermo Fisher Scientific, Inc.

Market Segmentation & Coverage

This research report categorizes the Microfluidics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Material
    • Glass-based
    • Polymer-based
    • Silicon-based
  • Component
    • Micro Needle
    • Micro Pump
    • Microfluidic Chip
  • Application
    • In-Vitro Diagnostics
      • Clinical Diagnostics
      • Point-Of-Care Testing
      • Veterinary Diagnostics
    • Pharmaceutical & Life Science Research
      • Lab Analytics
        • Capillary Electrophoresis
        • Cell-based Assays
        • Genomic analysis
        • Proteomic Analysis
      • Microdispensing
      • Microreaction
    • Therapeutics
      • Drug Delivery
      • Wearable Devices
  • End User
    • Academic & Research Institutes
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Microfluidics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Microfluidics Market?
  3. What are the technology trends and regulatory frameworks in the Microfluidics Market?
  4. What is the market share of the leading vendors in the Microfluidics Market?
  5. Which modes and strategic moves are suitable for entering the Microfluidics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Microfluidics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Incidence of Chronic Diseases and Increasing Demand for Point-Of-Care Testing
5.1.1.2. Improved Portability of Devices through Microfluidic Chip Miniaturization and Faster Turn-Around Time for Analysis
5.1.1.3. Potential Applications of Drug Delivery using Microfluidics
5.1.2. Restraints
5.1.2.1. Complicated and Time-Consuming Regulatory Approval Process
5.1.3. Opportunities
5.1.3.1. Development of Microfluidic-Based 3D Cell Culture Systems such as Organ-on-a-Chip
5.1.3.2. Advances in Microfluidic Components for Biomedical Analysis and Diagnostics
5.1.4. Challenges
5.1.4.1. Integration of Microfluidics with Existing Workflows
5.2. Market Segmentation Analysis
5.2.1. Material: Increasing use of glass and silicon-based materials for microfluidic devices
5.2.2. Component: Adoption of microneedles and pumps for minimal risk of infection
5.2.3. Application: Significant application of microfluidic devices in IVD and therapeutics
5.2.4. End User: Emerging use of microfluidics in research organizations and hospitals & diagnostics centers
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization
6. Microfluidics Market, by Material
6.1. Introduction
6.2. Glass-based
6.3. Polymer-based
6.4. Silicon-based
7. Microfluidics Market, by Component
7.1. Introduction
7.2. Micro Needle
7.3. Micro Pump
7.4. Microfluidic Chip
8. Microfluidics Market, by Application
8.1. Introduction
8.2. In-Vitro Diagnostics
8.3.1. Clinical Diagnostics
8.3.2. Point-Of-Care Testing
8.3.3. Veterinary Diagnostics
8.3. Pharmaceutical & Life Science Research
8.4.1. Lab Analytics
8.4.2.1. Capillary Electrophoresis
8.4.2.2. Cell-based Assays
8.4.2.3. Genomic analysis
8.4.2.4. Proteomic Analysis
8.4.2. Microdispensing
8.4.3. Microreaction
8.4. Therapeutics
8.5.1. Drug Delivery
8.5.2. Wearable Devices
9. Microfluidics Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Diagnostic Centers
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Microfluidics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Microfluidics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Microfluidics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Bio-Techne to acquire Swiss spatial biology firm Lunaphore
13.3.2. New Product Launch & Enhancement
13.3.2.1. CellFE Announces Launch of Novel Microfluidic Cellular Engineering Platform at ASGCT 2023 Annual Meeting
13.3.3. Investment & Funding
13.3.3.1. Astraveus Raises €16.5 Million Series Seed Round to Advance the Development of its Automated, Microfluidic Cell and Gene Therapy Manufacturing Platform
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abaxis, Inc.
14.1.2. Abbott Laboratories
14.1.3. AbCellera Biologics Inc.
14.1.4. Achira Labs Pvt. Ltd.
14.1.5. Agilent Technologies, Inc.
14.1.6. Ascent Bio-Nano Technologies, Inc.
14.1.7. Bio-Rad Laboratories, Inc.
14.1.8. BioFluidica
14.1.9. Biosurfit SA
14.1.10. Camozzi Automation S.p.A.
14.1.11. Cellix Limited
14.1.12. Danaher Corporation
14.1.13. Dolomite Microfluidics
14.1.14. Elvesys Group
14.1.15. Fluidigm Corporation by Standard BioTools Inc.
14.1.16. Fluigent S.A.
14.1.17. Idex Corporation
14.1.18. Illumina, Inc.
14.1.19. IMT Masks and Divisions AG
14.1.20. Koninklijke Philips N.V.
14.1.21. Micropoint Bioscience, Inc.
14.1.22. Mission Bio, Inc.
14.1.23. NanoCellect Biomedical.
14.1.24. OPKO Health, Inc.
14.1.25. Parker-Hannifin Corporation
14.1.26. PerkinElmer Inc.
14.1.27. Quidel Corporation
14.1.28. SMC Corporation
14.1.29. Sphere Fluidics Limited
14.1.30. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. MICROFLUIDICS MARKET RESEARCH PROCESS
FIGURE 2. MICROFLUIDICS MARKET SIZE, 2022 VS 2030
FIGURE 3. MICROFLUIDICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MICROFLUIDICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MICROFLUIDICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MICROFLUIDICS MARKET DYNAMICS
FIGURE 7. MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2022 VS 2030 (%)
FIGURE 8. MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 10. MICROFLUIDICS MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. MICROFLUIDICS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 14. MICROFLUIDICS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES MICROFLUIDICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. MICROFLUIDICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. MICROFLUIDICS MARKET SHARE, BY KEY PLAYER, 2022

Companies Mentioned

  • Abaxis, Inc.
  • Abbott Laboratories
  • AbCellera Biologics Inc.
  • Achira Labs Pvt. Ltd.
  • Agilent Technologies, Inc.
  • Ascent Bio-Nano Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioFluidica
  • Biosurfit SA
  • Camozzi Automation S.p.A.
  • Cellix Limited
  • Danaher Corporation
  • Dolomite Microfluidics
  • Elvesys Group
  • Fluidigm Corporation by Standard BioTools Inc.
  • Fluigent S.A.
  • Idex Corporation
  • Illumina, Inc.
  • IMT Masks and Divisions AG
  • Koninklijke Philips N.V.
  • Micropoint Bioscience, Inc.
  • Mission Bio, Inc.
  • NanoCellect Biomedical.
  • OPKO Health, Inc.
  • Parker-Hannifin Corporation
  • PerkinElmer Inc.
  • Quidel Corporation
  • SMC Corporation
  • Sphere Fluidics Limited
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information